CAN106
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAN106, covering 2022-09-14 to 2022-09-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH [Phase 1, Phase 2]